| GlaxoSmithKline AG - Relenza 5 mg, Disk (Pulverinhalation) |
| 55108 | | 01 | | Relenza 5 mg | | Disk (Pulverinhalation) | | J05AH01 | | Zanamivir | | 24.06.1999 | | |
|
| Composition |
| zanamivirum 5 mg pro dosi, lactosum monohydricum, ad pulverem. |
| Packungsbestandteile |
| Disk (Pulverinhalation) | | | | | | Active Agent | Dose |
|---|
| Zanamivir | 5 mg |
| | | | Inactive agents |
|---|
| Lactose Monohydrate |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 20 unidose(s) | PR | PR | B | | Yes |
|
